C
Cartherics
Developing the next generation of improved and optimized chimeric antigen receptor CAR-T cell products
About Cartherics
Cartherics is a pioneering company in the field of immunotherapy, focusing on developing novel, allogeneic immune cell therapy products for the treatment of solid cancers. The company leverages advanced gene editing and Chimeric Antigen Receptor (CAR) technology to create precisely defined immunotherapy treatments. These treatments are designed to be more precise and accessible, offering diverse off-the-shelf solutions for patients with various types of cancer. Cartherics operates in the biotechnology and healthcare market, serving patients, healthcare providers, and research institutions. The company's business model revolves around research and development, product commercialization, and strategic partnerships. Revenue is generated through the commercialization of its proprietary immunotherapy products, licensing agreements, and collaborations with other biotech firms and healthcare providers. The company has recently invested in a state-of-the-art facility in Victoria, which includes advanced laboratories, clean rooms, and biobanking facilities. This new lab is aimed at strengthening Cartherics' research and manufacturing capabilities, as well as supporting local innovation.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2014
- Headquarters
- Melbourne, Australia
- Employees
- 37
- Open positions
- 7
- Dealroom signal
- 71.2/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Oncology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GRANT✓Other financing | Dec 2024 | $300K | — | Undisclosed | ↗ |
| EARLY VC✓Equity / VC | Sep 2024 | $9.7M | $39M | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for Cartherics is 2.9K monthly website visits, up 26.1% over the last three months. Cartherics's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Innovation Connections
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Cartherics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Cartherics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.